Literature DB >> 32191342

Letter to the Editor: Emergence of Zoonotic Rat Hepatitis E Virus Infection.

Cornelia Adlhoch1, Sally A Baylis2.   

Abstract

Entities:  

Year:  2020        PMID: 32191342      PMCID: PMC7756569          DOI: 10.1002/hep.31241

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
To the Editor: We noted the identification of further rat hepatitis E virus (HEV) cases in humans in Hong Kong.( ) This emergence, infection of a Canadian United Nations worker in Africa,( ) and serological evidence of exposure in German foresters( ) and hospitalized Vietnamese patients( ) raises the question of how widespread rat HEV infection is globally. Rat HEV (Orthohepevirus C or HEV‐C) is distinct from epidemic HEV strains circulating in Africa, Asia, and to zoonotic pig strains responsible for disease burden in industrialized countries (Orthohepevirus A or HEV‐A). In Europe, hepatitis E is not notifiable, and, until recently, lack of awareness by physicians and poorly standardized diagnostics led to underreporting. In 2019, the European Centre for Disease Prevention and Control developed guidance on HEV surveillance (data collection/reporting, case definitions, and testing)( ); this and other guidelines do not currently consider HEV‐C. Despite similar clinical presentation of HEV‐C and HEV‐A (acute and chronic), molecular assays used clinically and for blood donor screening do not detect HEV‐C. A commonly used anti‐immunoglobulin M (IgM) assay can detect anti‐HEV‐C antibodies; however, HEV‐A/HEV‐C‐discriminatory assays are unavailable. Of the 169 anti‐IgM‐positive patients, Sridhar et al. identified 5 HEV‐C1 and 82 HEV‐A RNA‐positive patients.( ) Is more data on the remaining 82 HEV‐IgM‐positive/RNA‐negative patients available? Could variability of HEV‐C strains contribute to missed cases? There is a need to develop specific molecular and serological assays and associated control materials for HEV‐C, to assess case frequency in previously healthy immunocompetent as well as immunosuppressed individuals and understand the risk to humans. Zoonotic HEV‐A is transmitted primarily through consumption of contaminated meat. While Sridhar et al. mentioned the proximity of the HEV‐C‐infected patients to rat infestations and droppings, there was no discussion about possible transmission of HEV‐C by consumption of rat meat or contaminated meat products. More detailed epidemiological investigations (environmental risk factors, consumption habits, and water contamination) are needed to identify infection sources and transmission patterns.
  5 in total

1.  Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs.

Authors:  Paul Dremsek; Jürgen J Wenzel; Reimar Johne; Mario Ziller; Jörg Hofmann; Martin H Groschup; Sandra Werdermann; Ulrich Mohn; Silvia Dorn; Manfred Motz; Marc Mertens; Wolfgang Jilg; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2011-12-18       Impact factor: 3.402

2.  Rat Hepatitis E Virus Linked to Severe Acute Hepatitis in an Immunocompetent Patient.

Authors:  Anton Andonov; Mark Robbins; Jamie Borlang; Jingxin Cao; Todd Hatchette; Ashley Stueck; Yvon Deschambault; Kyle Murnaghan; Jessy Varga; Lynn Johnston
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

3.  Transmission of Rat Hepatitis E Virus Infection to Humans in Hong Kong: A Clinical and Epidemiological Analysis.

Authors:  Siddharth Sridhar; Cyril Chik-Yan Yip; Shusheng Wu; Nicholas Foo-Siong Chew; Kit-Hang Leung; Jasper Fuk-Woo Chan; Pyrear Suhui Zhao; Wan-Mui Chan; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Jian-Piao Cai; Helen Shuk-Ying Chan; Anthony Wai-Shing Leung; Cindy Wing-Sze Tse; Jonpaul Sze-Tsing Zee; Owen Tak-Yin Tsang; Vincent Chi-Chung Cheng; Susanna Kar-Pui Lau; Patrick Chiu-Yat Woo; Dominic Ngai-Chong Tsang; Kwok-Yung Yuen
Journal:  Hepatology       Date:  2020-10-12       Impact factor: 17.425

4.  Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.

Authors:  Cornelia Adlhoch; Zdenka Manďáková; Steen Ethelberg; Jevgenia Epštein; Ruska Rimhanen-Finne; Julie Figoni; Sally A Baylis; Mirko Faber; Kassiani Mellou; Niamh Murphy; Joanne O'Gorman; Maria Elena Tosti; Anna Rita Ciccaglione; Agnetha Hofhuis; Hans Zaaijer; Heidi Lange; Rita de Sousa; Ana Avellón; Lena Sundqvist; Bengü Said; Samreen Ijaz
Journal:  J Clin Virol       Date:  2019-09-19       Impact factor: 3.168

5.  Serological evidence of infection with rodent-borne hepatitis E virus HEV-C1 or antigenically related virus in humans.

Authors:  Kenta Shimizu; Sugihiro Hamaguchi; Cuong Chi Ngo; Tian-Cheng Li; Shuji Ando; Kumiko Yoshimatsu; Shumpei P Yasuda; Takaaki Koma; Rie Isozumi; Yoshimi Tsuda; Hiromi Fujita; Thuy Thanh Pham; Mai Quynh LE; Anh Duc Dang; Tuan Quang Nguyen; Lay-Myint Yoshida; Koya Ariyoshi; Jiro Arikawa
Journal:  J Vet Med Sci       Date:  2016-08-07       Impact factor: 1.267

  5 in total
  2 in total

1.  Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections.

Authors:  Claudia Minosse; Daniele Lapa; Antonio Coppola; Federica Rapagna; Gianpiero D'Offizi; Chiara Taibi; Raffaella Lionetti; Maria Rosaria Capobianchi; Fiona McPhee; Anna Rosa Garbuglia
Journal:  Viruses       Date:  2021-02-03       Impact factor: 5.048

2.  Hepatitis E Outbreak in the Central Part of Italy Sustained by Multiple HEV Genotype 3 Strains, June-December 2019.

Authors:  Anna Rosa Garbuglia; Roberto Bruni; Umbertina Villano; Francesco Vairo; Daniele Lapa; Elisabetta Madonna; Giovanna Picchi; Barbara Binda; Rinalda Mariani; Francesca De Paulis; Stefania D'Amato; Alessandro Grimaldi; Paola Scognamiglio; Maria Rosaria Capobianchi; Anna Rita Ciccaglione
Journal:  Viruses       Date:  2021-06-17       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.